Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is slated to report third-quarter 2025 results on Nov. 5, before the opening bell.
Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...
Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
18h
Evolutionary comparison points to pigs as superior models for human pancreas and diabetes research
Pancreas development in pigs resembles humans much more closely than does the established mouse model. An international team ...
Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...
Intellia Therapeutics, Inc. is rated Hold due to uncertainty from dosing pause in its MAGNITUDE program for ATTR. Learn more ...
The inaugural TCCI AI-Driven Science Symposium was held in San Francisco from Monday to Tuesday, bringing together three ...
The mice model technologies market offers significant opportunities driven by advancements in genetic engineering, particularly CRISPR/Cas9, fueling drug discovery in oncology, neurobiology, and ...
Mutations in ZRSR2 have been linked with disease progression in patients with JAK2 V617R – driven myeloproliferative neoplasms (MPNs), but a new report suggests that loss of ZRSR2 alone is not ...
A new study has revealed that the gene HMGN1 is a key driver of congenital heart defects (CHDs) in Down syndrome. Using ...
At CART High near Fresno, there is no gum stuck to the floor. The saffron-yellow walls are unmarred by graffiti. Toting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback